相关实验视频

Updated: Jan 7, 2026

The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool

The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool

Published on: June 30, 2014

卡帕指数预测了多发性硬化症的疾病活性和过渡到高效疗法

Simone Marcheselli¹, Federica Galota¹, Patrizia Natali²

¹Department of Biomedical, Metabolic and Neurosciences, Università degli Studi di Modena e Reggio Emilia, Modena, MO, Italy.

Clinical chemistry and laboratory medicine

|December 27, 2025

概括

多发性硬化症 (MS) 诊断时的卡帕指数预测了疾病活动和需要高效疗法 (HET) 的需求. 高值表明NEDA3损失和HET启动的风险更高,有助于早期治疗决策.

科学领域:

神经学神经学
免疫学免疫学免疫学
生物标志物生物标志物

背景情况:

卡帕指数显示了多发性硬化症 (MS) 的诊断潜力.
它对预测疾病活动和治疗反应的预后价值需要进一步研究.
早期识别需要先进治疗的患者对于管理多发性硬化症至关重要.

研究的目的:

在疾病发作时评估卡帕指数作为疾病活动的预测指标.
评估卡帕指数在预测高效疗法 (HET) 启动方面的作用.
为了确定卡帕指数值是否可以识别需要立即HET的MS患者.

主要方法:

分析了120名MS患者的队列,基线卡帕指数值和至少两年的随访时间.
主要结局:没有疾病活性-3 (NEDA3) 的证据消失的时间.
二次结果:时间到HET启动.

主要成果:

高卡帕指数值 (切断值>38) 独立预测了NEDA3损失 (HR 1.75) 和HET启动 (HR 3.25).
高卡帕指数值也预测在初始中度疗效疗法 (MET) 失败后 (HR 2.54) 过渡到HET.
74%的患者经历了NEDA3损失,28%的患者在随访期间启动了HET.

结论:

卡帕指数在MS诊断时是一个有价值的预后工具.
高卡帕指数值预测疾病活动和需要HET.
这种生物标志物可能有助于识别MS患者,这些患者可以从迅速启动HET中受益.

关键词:

卡帕指数是卡帕的指数.在NEDA3中,它是NEDA3的.多发性硬化症多发性硬化症预后预后预后治疗失败的治疗失败.

更多相关视频

Predictive Immune Modeling of Solid Tumors

Predictive Immune Modeling of Solid Tumors

Published on: February 25, 2020

Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis

Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis

Published on: September 9, 2022

相关概念视频

Kaplan-Meier Approach

Kaplan-Meier Approach

The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...

Therapeutic Index

Therapeutic Index

The therapeutic index of a drug is a key parameter in pharmacology that quantifies the relative safety of a drug by calculating the ratio between the dose that causes toxicity in half the population (50%) to the dose that proves to be effective for half the population (50%). It provides a spectrum of doses for a particular drug ranging from effective to potentially toxic. To illustrate, consider an anticoagulant agent like warfarin. It possesses a narrow window within its therapeutic index to...

Therapeutic Drug Monitoring: Affecting Factors

Therapeutic Drug Monitoring: Affecting Factors

Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.